Storia in 2 fonti

Hope for thousands as new drug cuts prostate cancer relapse risk

Thousands of men with advanced prostate cancer could soon live longer thanks to a treatment which cuts the risk of the disease returning by nearly a third.

Raccontata da

dailymail.com

mirror.co.uk

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

dailymail.comStai leggendo3 mesi fa

Hope for thousands as new drug cuts prostate cancer relapse risk

Apalutamide (Erleada), added to standard androgen deprivation therapy, reduced prostate cancer relapse risk by 29% over five years in a 2,100-patient phase 3 trial (PROTEUS), extending progression-free survival from ~3 to ~5 years. For health-tech and pharma-adjacent managers, this signals a shift toward combination ADT protocols that will drive formulary updates and reimbursement negotiations across EU markets.

originale

mirror.co.uk3 mesi fa

Cancer breakthrough as new 'game-changing' pill could double survival time

Prostate cancer patients normally have a devastatingly short life expectancy - but the new daily pill being offered in clinical trials could change that

Hope for thousands as new drug cuts prostate cancer relapse risk

Cancer breakthrough as new 'game-changing' pill could double survival time

Timeline cronologica

Hope for thousands as new drug cuts prostate cancer relapse risk

Cancer breakthrough as new 'game-changing' pill could double survival time